Tg Therapeutics (TGTX) Non Operating Income (2011 - 2026)

Tg Therapeutics' Non Operating Income history runs 16 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 175.68% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $23.0 million (up 195.19% YoY), while the FY2025 annual figure was $10.8 million, up 166.07% from the prior year.
• Non Operating Income was $2.4 million for Q1 2026 at Tg Therapeutics, down from $21.3 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $21.3 million in Q4 2025 to a low of -$21.5 million in Q4 2024.
• Historically, Non Operating Income has averaged $132647.1 across 5 years, with a median of -$854000.0 in 2023.
• Biggest YoY gain for Non Operating Income was 412.18% in 2024; the steepest drop was 2511.57% in 2024.
• A 5-year view of Non Operating Income shows it stood at $9.3 million in 2022, then plunged by 90.39% to $890000.0 in 2023, then slumped by 2511.57% to -$21.5 million in 2024, then soared by 199.36% to $21.3 million in 2025, then tumbled by 88.81% to $2.4 million in 2026.
• The last three Non Operating Income figures came in at $2.4 million (Q1 2026), $21.3 million (Q4 2025), and -$3.5 million (Q3 2025), per Business Quant data.